Jitrocel Sanofi

Dry extract of ribwort plantain, the active ingredient in Jitrocel Sanofi, is a herbal extract presented as an oral preparation for systemic use. It is traditionally employed to support respiratory comfort and mild inflammatory conditions.

GNH USA supplies Jitrocel Sanofi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance.

Jitrocel Sanofi, containing dry extract of ribwort plantain, is used in supportive care for respiratory and mild inflammatory conditions. - Cough: helps soothe throat irritation and reduce cough frequency. - Upper respiratory tract infection: may provide symptomatic relief of congestion and sore throat. - Minor inflammatory conditions: may assist in reducing mild inflammation of mucous membranes.

Oral administration of ribwort plantain extract may be associated with the following adverse reactions.

Common Side Effects: - Gastrointestinal discomfort: mild nausea or stomach upset. - Allergic skin reaction: localized rash or itching. - Taste alteration: temporary change in taste perception.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Hepatic dysfunction: abnormal liver enzyme levels reported rarely. - Hemorrhagic events: potential increased bleeding risk in susceptible individuals.

Before using Jitrocel Sanofi, consider the following precautions. - Allergy assessment: avoid if known hypersensitivity to plantain or related species. - Pregnancy and lactation: safety not established; use only if clearly needed and prescribed. - Concomitant anticoagulants: monitor for enhanced bleeding tendency. - Chronic liver disease: exercise caution and monitor liver function. - Store at ambient temperature: keep below 25 °C, protect from moisture and direct sunlight.

Potential drug interactions with ribwort plantain extract should be reviewed.

Major Interactions (Avoid): - Warfarin: may potentiate anticoagulant effect, increasing bleeding risk. - Immunosuppressants: potential alteration of immune response, monitor closely.

Moderate Interactions (Monitor Closely): - Diuretics: possible additive diuretic effect, watch electrolyte balance. - Antihypertensives: may enhance blood pressure lowering, observe for hypotension. - Antiplatelet agents: may increase bleeding tendency, require periodic assessment.